SlideShare a Scribd company logo
EMDMillipore.com
The life science business of Merck KGaA, Darmstadt, Germany
operates as MilliporeSigma in the U.S. and Canada.
Introduction
Final sterile filtration of formulated medicinal products is
performed late in production operations in a highly controlled
aseptic environment.
Final sterile filtration operations are the focus of extensive
regulatory guidance to assure the safety of these medicinal
products for administration to patients. All sterilizing-grade
filters must be tested for integrity after use, and current draft
EMA EU Annex 1 requires pre-use, post-sterilization integrity
tests (PUPSIT).
Millipak® Final Fill filters simplify PUPSIT by reducing the risk of
introducing microbial contaminants to the flow path: an aseptic
multi-purpose port (AMPP) provides a barrier between the
outside air and aseptic flow path during filter integrity testing.
While the selection of sterilizing-grade membranes is
traditionally based on performance, compatibility and quality,
filter format has a direct impact on the volume of product
recovered. Product retained by the membrane, support material,
and capsule is non-recoverable and is referred to as hold-up
volume. High hold-up volume has direct financial implications
due to the high value of final product.
This poster summarizes studies that confirm Millipak® Final Fill
filters maintain an aseptic flow path following multiple actuations
and demonstrates methods to maximize product recovery for
safer and more efficient final filtration processing.
Figure 1 Millipak® Final Fill Filters
Reducing Contamination
Risks
To assess the capability of the AMPP in preventing microbial
ingress, challenge testing was performed with Brevundimonas
diminuta (ATCC® 19146), the standard organism used for
sterilizing-grade filter retention testing.
Millipak® Final Fill Filters were gamma irradiated or gamma
irradiated followed by autoclaving. The AMPP was then
challenged with B. diminuta as indicated in Figure 2 and
actuated at least 18 times.
All tests were run in triplicate and included positive controls
(AMPP without O-rings) to confirm low levels of inoculum could
be detected, and negative controls (no microbial challenge) to
confirm the method could be run aseptically.
Figure 2. Summary of tests demonstrating microbial integrity of AMPP
following sterilization and actuations.
No microbial growth was detected in samples from any of the
test devices after challenge testing, confirming the AMPP
provides a barrier preventing bacteria from entering the flow
path during integrity testing and sampling.
Reducing Contamination Risk and Improving
Product Recovery During Final Sterile Filtration
© 2019 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. MilliporeSigma, Millipore, the vibrant M, Millipak, and Durapore are
trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of their respective owners. Detailed information
on trademarks is available via publicly accessible resources.
Lit. No. MS_PS4779EN Ver. 1.0 10/2019
Maximizing Product Recovery
For biopharmaceutical manufacturers, maximizing product recovery is
key to achieving process efficiency. The stacked disc format of Millipak®
Final Fill filters is designed to reduce hold-up volume as compared to
traditional pleated filters. However, incorporating a filter blow-down with
a short pressure hold at 20 psi above the filter’s bubble point
specification can further reduce the hold-up volume in the filter and
increase product recovery. Figure 3 shows the hold-up volumes of
pleated and stacked disc filters of different membrane areas containing
sterilizing-grade membrane following blow-down through the filter inlet.
Figure 3: Mean hold-up volume of pleated filters compared to Millipak® Final Fill
filters following a 1 minute blow-down with air through the filter inlet at 20 psi above the
filter’s bubble point specification.
After blow-down, the hold-up volumes of Millipak® Final Fill filters are
1.5-5 times lower than those of pleated filters across all filtration areas.
Reducing hold-up volume can impact the economics of filtration
operations, especially when considering larger area pleated filters.
Figure 4 illustrates potential revenue impact for products at different
price points when processed over pleated and stacked disc filters of
~1000 cm2. All costs are based on product recovery volumes following
blow-down with air through the filter inlet for 1 minute at 20 psi above
the filter’s bubble point specification.
Figure 4: Revenue impact to manufacturer for medicinal products at different price
points due to hold-up volume (after blow-down) in pleated filters and Millipak® Final Fill
200 filters containing Durapore® 0.22 µm membrane.
The economic benefit of reduced hold-up volume is highly dependent on
the dollar value of the products being processed. As the product price
increases, the benefit differential between filter formats also increases,
with the maximum benefit of the stacked disc filters aligning with high
price medicinal products.
Conclusions
Final sterile filtration operations are evolving with the development of filtration devices that meet the requirements of critical process steps
while providing sterility assurance and greater operational efficiency. Results presented here demonstrate that Millipak® Final Fill filters
offer several advantages for maintaining an aseptic flow path, maximizing product recovery, as well as streamlining mandatory integrity
testing operations. The advanced capabilities of the filter design simplify and improve process risk mitigation and yield, ensuring consistent
and reliable performance during final filtration.
Simplified Integrity Testing
and Product Recovery
Single-use systems are increasingly being adopted in final
filtration and the AMPP offers opportunities for a streamlined
single-use assembly design with fewer connections. Figure 5
illustrates a simplified design for performing integrity testing or
blow-down through the AMPP using automated integrity
testers.
Figure 5: System configuration for connecting automated integrity testers
to sterilizing-grade filters: A – connection through the filter inlet; B –
connection through the AMPP on Millipak® Final Fill filters.
Bubble point testing through the AMPP and inlet generate
equivalent bubble point values (data not shown).
In addition to the filter inlet, filter blow-down can be performed
through the AMPP using an automated tester to deliver a short,
elevated pressure hold. Using the AMPP, rather than the filter
inlet streamlines integrity testing operations by minimizing
contamination risks and reducing the number of connections
required. Figure 6 shows hold-up volumes of Millipak® Final Fill
200 filters following different drain and blow-down methods
through the filter inlet and AMPP.
Figure 6: Mean hold-up volume of Millipak® Final Fill 200 filters containing
sterilizing–grade Durapore® 0.22 µm membrane following gravity drain,
pressure increase to 55 psig (membrane’s bubble point) and a 1 minute
pressure hold to 70 psig (20 psi above the membrane’s bubble point) applied
through the filter inlet or AMPP.
Results confirm that filter hold-up volumes following elevated
pressure hold are similar, irrespective if the pressure is applied
through the inlet or the AMPP. Blow-down through the AMPP
with an automated tester at the membrane’s bubble point
pressure specification also reduces hold-up volume as
compared to gravity draining.
Using the AMPP to recover product from the filter with an
automated tester simplifies recovery, eliminating the need to
switch to a controlled pressurized gas source.
Ranjani Sundharam, An Son Leong, Lauren Kacmarcik, Andrew Koch
MilliporeSigma, 80 Ashby Road, Bedford, MA 01730
A B
0
10
20
30
40
50
60
70
Blow-down Method
Hold-upvolume(mL)
Hold-up of Millipak® Final Fill 200 Filters
Following Blow-down
Gravity Drain
Pressure increase to membrane BP through AMPP
Presssure through inlet to 20 psi above BP for 1 min
Pressure through AMPP to 20 psi above BP for 1 min

More Related Content

What's hot

Aseptic Process Sampling to address Risk of Contamination & Containment in co...
Aseptic Process Sampling to address Risk of Contamination & Containment in co...Aseptic Process Sampling to address Risk of Contamination & Containment in co...
Aseptic Process Sampling to address Risk of Contamination & Containment in co...
MilliporeSigma
 
Using Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC ProcessingUsing Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC Processing
Merck Life Sciences
 
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Merck Life Sciences
 
PVA for sustained release: theory and practice
PVA for sustained release: theory and practicePVA for sustained release: theory and practice
PVA for sustained release: theory and practice
MilliporeSigma
 
White Paper: Explore Versatility with SPTFF
White Paper: Explore Versatility with SPTFFWhite Paper: Explore Versatility with SPTFF
White Paper: Explore Versatility with SPTFF
Merck Life Sciences
 
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb PurificationMembrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
MilliporeSigma
 
Normal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale UpNormal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale Up
Merck Life Sciences
 
Millipak® Final Fill Filters
Millipak® Final Fill FiltersMillipak® Final Fill Filters
Millipak® Final Fill Filters
MilliporeSigma
 
Filtration Strategies for Optimal Development and Purification of a FMD Virus...
Filtration Strategies for Optimal Development and Purification of a FMD Virus...Filtration Strategies for Optimal Development and Purification of a FMD Virus...
Filtration Strategies for Optimal Development and Purification of a FMD Virus...
Merck Life Sciences
 
Normal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale UpNormal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale Up
MilliporeSigma
 
Addressing handling challenges of chemicals by dry granulation
Addressing handling challenges of chemicals by dry granulationAddressing handling challenges of chemicals by dry granulation
Addressing handling challenges of chemicals by dry granulation
MilliporeSigma
 
Total cost of ownership – how the choice of excipients makes your economics
Total cost of ownership – how the choice of excipients makes your economicsTotal cost of ownership – how the choice of excipients makes your economics
Total cost of ownership – how the choice of excipients makes your economics
MilliporeSigma
 
Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Find your filter. What’s best for your process?
Find your filter. What’s best for your process?
Merck Life Sciences
 
Does PUPSIT Reduce Risk for Sterile Filtration?
Does PUPSIT Reduce Risk for Sterile Filtration?Does PUPSIT Reduce Risk for Sterile Filtration?
Does PUPSIT Reduce Risk for Sterile Filtration?
Merck Life Sciences
 
Tx Single Use Seminar Jun09
Tx Single Use Seminar Jun09Tx Single Use Seminar Jun09
Tx Single Use Seminar Jun09Mark_Perreault
 
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
MilliporeSigma
 
Validation of water supply system
Validation of water supply systemValidation of water supply system
Validation of water supply systemceutics1315
 

What's hot (17)

Aseptic Process Sampling to address Risk of Contamination & Containment in co...
Aseptic Process Sampling to address Risk of Contamination & Containment in co...Aseptic Process Sampling to address Risk of Contamination & Containment in co...
Aseptic Process Sampling to address Risk of Contamination & Containment in co...
 
Using Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC ProcessingUsing Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC Processing
 
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
 
PVA for sustained release: theory and practice
PVA for sustained release: theory and practicePVA for sustained release: theory and practice
PVA for sustained release: theory and practice
 
White Paper: Explore Versatility with SPTFF
White Paper: Explore Versatility with SPTFFWhite Paper: Explore Versatility with SPTFF
White Paper: Explore Versatility with SPTFF
 
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb PurificationMembrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
 
Normal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale UpNormal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale Up
 
Millipak® Final Fill Filters
Millipak® Final Fill FiltersMillipak® Final Fill Filters
Millipak® Final Fill Filters
 
Filtration Strategies for Optimal Development and Purification of a FMD Virus...
Filtration Strategies for Optimal Development and Purification of a FMD Virus...Filtration Strategies for Optimal Development and Purification of a FMD Virus...
Filtration Strategies for Optimal Development and Purification of a FMD Virus...
 
Normal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale UpNormal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale Up
 
Addressing handling challenges of chemicals by dry granulation
Addressing handling challenges of chemicals by dry granulationAddressing handling challenges of chemicals by dry granulation
Addressing handling challenges of chemicals by dry granulation
 
Total cost of ownership – how the choice of excipients makes your economics
Total cost of ownership – how the choice of excipients makes your economicsTotal cost of ownership – how the choice of excipients makes your economics
Total cost of ownership – how the choice of excipients makes your economics
 
Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Find your filter. What’s best for your process?
Find your filter. What’s best for your process?
 
Does PUPSIT Reduce Risk for Sterile Filtration?
Does PUPSIT Reduce Risk for Sterile Filtration?Does PUPSIT Reduce Risk for Sterile Filtration?
Does PUPSIT Reduce Risk for Sterile Filtration?
 
Tx Single Use Seminar Jun09
Tx Single Use Seminar Jun09Tx Single Use Seminar Jun09
Tx Single Use Seminar Jun09
 
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
 
Validation of water supply system
Validation of water supply systemValidation of water supply system
Validation of water supply system
 

Similar to Reducing Contamination Risk and Improving Product Recovery During Final Sterile Filtration

Millipak® Final Fill Filters Reduce Contamination Risks and Simplify Filtrati...
Millipak® Final Fill Filters Reduce Contamination Risks and Simplify Filtrati...Millipak® Final Fill Filters Reduce Contamination Risks and Simplify Filtrati...
Millipak® Final Fill Filters Reduce Contamination Risks and Simplify Filtrati...
MilliporeSigma
 
Redesigned Filter Capsule Improves Final Filtration Assembly Design and Opera...
Redesigned Filter Capsule Improves Final Filtration Assembly Design and Opera...Redesigned Filter Capsule Improves Final Filtration Assembly Design and Opera...
Redesigned Filter Capsule Improves Final Filtration Assembly Design and Opera...
MilliporeSigma
 
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On ExperienceParvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
MilliporeSigma
 
Improved Product Recovery Using Blow-down and Millipak® Final Fill Filters
Improved Product Recovery Using Blow-down and Millipak® Final Fill FiltersImproved Product Recovery Using Blow-down and Millipak® Final Fill Filters
Improved Product Recovery Using Blow-down and Millipak® Final Fill Filters
MilliporeSigma
 
Pellicon 2
Pellicon 2Pellicon 2
Pellicon 2
Arash Abed
 
Filtration Strategies for Optimal Development and Purification of a FMD Virus...
Filtration Strategies for Optimal Development and Purification of a FMD Virus...Filtration Strategies for Optimal Development and Purification of a FMD Virus...
Filtration Strategies for Optimal Development and Purification of a FMD Virus...
MilliporeSigma
 
GMP sterile products
GMP sterile products GMP sterile products
GMP sterile products
surafel kebede
 
Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed Processing
MilliporeSigma
 
Filter validation
Filter validationFilter validation
Filter validation
VINOTH R
 
Industrial Applications Of Chromatography Technique
Industrial Applications Of Chromatography TechniqueIndustrial Applications Of Chromatography Technique
Industrial Applications Of Chromatography Technique
rita martin
 
GMP Requirements for Sterile Products manufacturing
GMP Requirements for Sterile Products manufacturingGMP Requirements for Sterile Products manufacturing
GMP Requirements for Sterile Products manufacturing
surafel kebede
 
GMP Requirements for Sterile Products manufacturing
GMP Requirements for Sterile Products manufacturingGMP Requirements for Sterile Products manufacturing
GMP Requirements for Sterile Products manufacturing
surafel kebede
 
Using Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC ProcessingUsing Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC Processing
MilliporeSigma
 
Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Find your filter. What’s best for your process?
Find your filter. What’s best for your process?
MilliporeSigma
 
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
MilliporeSigma
 
Pharmaceutical Engineering Downflow Booth Testing
Pharmaceutical Engineering Downflow Booth TestingPharmaceutical Engineering Downflow Booth Testing
Pharmaceutical Engineering Downflow Booth TestingEric Ferguson
 
Camfil Truly Green Air Filters Brochure
Camfil Truly Green Air Filters BrochureCamfil Truly Green Air Filters Brochure
Camfil Truly Green Air Filters BrochureAdam Wiggins
 
Care and use manual waters x bridge columns
Care and use manual waters x bridge columnsCare and use manual waters x bridge columns
Care and use manual waters x bridge columns
John Omondi
 
Testing/Manufacture/Flat Sheet Media
Testing/Manufacture/Flat Sheet Media  Testing/Manufacture/Flat Sheet Media
Testing/Manufacture/Flat Sheet Media
fec2020
 
Testing/Manufacture/flat sheet medi 2
Testing/Manufacture/flat sheet medi   2Testing/Manufacture/flat sheet medi   2
Testing/Manufacture/flat sheet medi 2
fec2020
 

Similar to Reducing Contamination Risk and Improving Product Recovery During Final Sterile Filtration (20)

Millipak® Final Fill Filters Reduce Contamination Risks and Simplify Filtrati...
Millipak® Final Fill Filters Reduce Contamination Risks and Simplify Filtrati...Millipak® Final Fill Filters Reduce Contamination Risks and Simplify Filtrati...
Millipak® Final Fill Filters Reduce Contamination Risks and Simplify Filtrati...
 
Redesigned Filter Capsule Improves Final Filtration Assembly Design and Opera...
Redesigned Filter Capsule Improves Final Filtration Assembly Design and Opera...Redesigned Filter Capsule Improves Final Filtration Assembly Design and Opera...
Redesigned Filter Capsule Improves Final Filtration Assembly Design and Opera...
 
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On ExperienceParvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
 
Improved Product Recovery Using Blow-down and Millipak® Final Fill Filters
Improved Product Recovery Using Blow-down and Millipak® Final Fill FiltersImproved Product Recovery Using Blow-down and Millipak® Final Fill Filters
Improved Product Recovery Using Blow-down and Millipak® Final Fill Filters
 
Pellicon 2
Pellicon 2Pellicon 2
Pellicon 2
 
Filtration Strategies for Optimal Development and Purification of a FMD Virus...
Filtration Strategies for Optimal Development and Purification of a FMD Virus...Filtration Strategies for Optimal Development and Purification of a FMD Virus...
Filtration Strategies for Optimal Development and Purification of a FMD Virus...
 
GMP sterile products
GMP sterile products GMP sterile products
GMP sterile products
 
Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed Processing
 
Filter validation
Filter validationFilter validation
Filter validation
 
Industrial Applications Of Chromatography Technique
Industrial Applications Of Chromatography TechniqueIndustrial Applications Of Chromatography Technique
Industrial Applications Of Chromatography Technique
 
GMP Requirements for Sterile Products manufacturing
GMP Requirements for Sterile Products manufacturingGMP Requirements for Sterile Products manufacturing
GMP Requirements for Sterile Products manufacturing
 
GMP Requirements for Sterile Products manufacturing
GMP Requirements for Sterile Products manufacturingGMP Requirements for Sterile Products manufacturing
GMP Requirements for Sterile Products manufacturing
 
Using Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC ProcessingUsing Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC Processing
 
Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Find your filter. What’s best for your process?
Find your filter. What’s best for your process?
 
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
 
Pharmaceutical Engineering Downflow Booth Testing
Pharmaceutical Engineering Downflow Booth TestingPharmaceutical Engineering Downflow Booth Testing
Pharmaceutical Engineering Downflow Booth Testing
 
Camfil Truly Green Air Filters Brochure
Camfil Truly Green Air Filters BrochureCamfil Truly Green Air Filters Brochure
Camfil Truly Green Air Filters Brochure
 
Care and use manual waters x bridge columns
Care and use manual waters x bridge columnsCare and use manual waters x bridge columns
Care and use manual waters x bridge columns
 
Testing/Manufacture/Flat Sheet Media
Testing/Manufacture/Flat Sheet Media  Testing/Manufacture/Flat Sheet Media
Testing/Manufacture/Flat Sheet Media
 
Testing/Manufacture/flat sheet medi 2
Testing/Manufacture/flat sheet medi   2Testing/Manufacture/flat sheet medi   2
Testing/Manufacture/flat sheet medi 2
 

More from MilliporeSigma

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
MilliporeSigma
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
MilliporeSigma
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
MilliporeSigma
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
MilliporeSigma
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
MilliporeSigma
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
MilliporeSigma
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
MilliporeSigma
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
MilliporeSigma
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
MilliporeSigma
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
MilliporeSigma
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
MilliporeSigma
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
MilliporeSigma
 
How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?
MilliporeSigma
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
MilliporeSigma
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
MilliporeSigma
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
MilliporeSigma
 
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
MilliporeSigma
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
MilliporeSigma
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
MilliporeSigma
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
MilliporeSigma
 

More from MilliporeSigma (20)

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
 
How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
 
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
 

Recently uploaded

HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
priyabhojwani1200
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
Dinesh Chauhan
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
Sachin Sharma
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
khvdq584
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Sankalpa Gunathilaka
 
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...
Kumar Satyam
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Kumar Satyam
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
Radhika kulvi
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
RXOOM Healthcare Pvt. Ltd. ​
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
ranishasharma67
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
ranishasharma67
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
Pooja Rani
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Health Catalyst
 
TOP AND BEST GLUTE BUILDER A 606 | Fitking Fitness
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessTOP AND BEST GLUTE BUILDER A 606 | Fitking Fitness
TOP AND BEST GLUTE BUILDER A 606 | Fitking Fitness
Fitking Fitness
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 

Recently uploaded (20)

HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
 
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsxChild Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
Child Welfare Clinic and Well baby clinicin Sri Lanka.ppsx
 
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
Neuro Saphirex Cranial Brochure
Neuro Saphirex Cranial BrochureNeuro Saphirex Cranial Brochure
Neuro Saphirex Cranial Brochure
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
 
TOP AND BEST GLUTE BUILDER A 606 | Fitking Fitness
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessTOP AND BEST GLUTE BUILDER A 606 | Fitking Fitness
TOP AND BEST GLUTE BUILDER A 606 | Fitking Fitness
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 

Reducing Contamination Risk and Improving Product Recovery During Final Sterile Filtration

  • 1. EMDMillipore.com The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. Introduction Final sterile filtration of formulated medicinal products is performed late in production operations in a highly controlled aseptic environment. Final sterile filtration operations are the focus of extensive regulatory guidance to assure the safety of these medicinal products for administration to patients. All sterilizing-grade filters must be tested for integrity after use, and current draft EMA EU Annex 1 requires pre-use, post-sterilization integrity tests (PUPSIT). Millipak® Final Fill filters simplify PUPSIT by reducing the risk of introducing microbial contaminants to the flow path: an aseptic multi-purpose port (AMPP) provides a barrier between the outside air and aseptic flow path during filter integrity testing. While the selection of sterilizing-grade membranes is traditionally based on performance, compatibility and quality, filter format has a direct impact on the volume of product recovered. Product retained by the membrane, support material, and capsule is non-recoverable and is referred to as hold-up volume. High hold-up volume has direct financial implications due to the high value of final product. This poster summarizes studies that confirm Millipak® Final Fill filters maintain an aseptic flow path following multiple actuations and demonstrates methods to maximize product recovery for safer and more efficient final filtration processing. Figure 1 Millipak® Final Fill Filters Reducing Contamination Risks To assess the capability of the AMPP in preventing microbial ingress, challenge testing was performed with Brevundimonas diminuta (ATCC® 19146), the standard organism used for sterilizing-grade filter retention testing. Millipak® Final Fill Filters were gamma irradiated or gamma irradiated followed by autoclaving. The AMPP was then challenged with B. diminuta as indicated in Figure 2 and actuated at least 18 times. All tests were run in triplicate and included positive controls (AMPP without O-rings) to confirm low levels of inoculum could be detected, and negative controls (no microbial challenge) to confirm the method could be run aseptically. Figure 2. Summary of tests demonstrating microbial integrity of AMPP following sterilization and actuations. No microbial growth was detected in samples from any of the test devices after challenge testing, confirming the AMPP provides a barrier preventing bacteria from entering the flow path during integrity testing and sampling. Reducing Contamination Risk and Improving Product Recovery During Final Sterile Filtration © 2019 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. MilliporeSigma, Millipore, the vibrant M, Millipak, and Durapore are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources. Lit. No. MS_PS4779EN Ver. 1.0 10/2019 Maximizing Product Recovery For biopharmaceutical manufacturers, maximizing product recovery is key to achieving process efficiency. The stacked disc format of Millipak® Final Fill filters is designed to reduce hold-up volume as compared to traditional pleated filters. However, incorporating a filter blow-down with a short pressure hold at 20 psi above the filter’s bubble point specification can further reduce the hold-up volume in the filter and increase product recovery. Figure 3 shows the hold-up volumes of pleated and stacked disc filters of different membrane areas containing sterilizing-grade membrane following blow-down through the filter inlet. Figure 3: Mean hold-up volume of pleated filters compared to Millipak® Final Fill filters following a 1 minute blow-down with air through the filter inlet at 20 psi above the filter’s bubble point specification. After blow-down, the hold-up volumes of Millipak® Final Fill filters are 1.5-5 times lower than those of pleated filters across all filtration areas. Reducing hold-up volume can impact the economics of filtration operations, especially when considering larger area pleated filters. Figure 4 illustrates potential revenue impact for products at different price points when processed over pleated and stacked disc filters of ~1000 cm2. All costs are based on product recovery volumes following blow-down with air through the filter inlet for 1 minute at 20 psi above the filter’s bubble point specification. Figure 4: Revenue impact to manufacturer for medicinal products at different price points due to hold-up volume (after blow-down) in pleated filters and Millipak® Final Fill 200 filters containing Durapore® 0.22 µm membrane. The economic benefit of reduced hold-up volume is highly dependent on the dollar value of the products being processed. As the product price increases, the benefit differential between filter formats also increases, with the maximum benefit of the stacked disc filters aligning with high price medicinal products. Conclusions Final sterile filtration operations are evolving with the development of filtration devices that meet the requirements of critical process steps while providing sterility assurance and greater operational efficiency. Results presented here demonstrate that Millipak® Final Fill filters offer several advantages for maintaining an aseptic flow path, maximizing product recovery, as well as streamlining mandatory integrity testing operations. The advanced capabilities of the filter design simplify and improve process risk mitigation and yield, ensuring consistent and reliable performance during final filtration. Simplified Integrity Testing and Product Recovery Single-use systems are increasingly being adopted in final filtration and the AMPP offers opportunities for a streamlined single-use assembly design with fewer connections. Figure 5 illustrates a simplified design for performing integrity testing or blow-down through the AMPP using automated integrity testers. Figure 5: System configuration for connecting automated integrity testers to sterilizing-grade filters: A – connection through the filter inlet; B – connection through the AMPP on Millipak® Final Fill filters. Bubble point testing through the AMPP and inlet generate equivalent bubble point values (data not shown). In addition to the filter inlet, filter blow-down can be performed through the AMPP using an automated tester to deliver a short, elevated pressure hold. Using the AMPP, rather than the filter inlet streamlines integrity testing operations by minimizing contamination risks and reducing the number of connections required. Figure 6 shows hold-up volumes of Millipak® Final Fill 200 filters following different drain and blow-down methods through the filter inlet and AMPP. Figure 6: Mean hold-up volume of Millipak® Final Fill 200 filters containing sterilizing–grade Durapore® 0.22 µm membrane following gravity drain, pressure increase to 55 psig (membrane’s bubble point) and a 1 minute pressure hold to 70 psig (20 psi above the membrane’s bubble point) applied through the filter inlet or AMPP. Results confirm that filter hold-up volumes following elevated pressure hold are similar, irrespective if the pressure is applied through the inlet or the AMPP. Blow-down through the AMPP with an automated tester at the membrane’s bubble point pressure specification also reduces hold-up volume as compared to gravity draining. Using the AMPP to recover product from the filter with an automated tester simplifies recovery, eliminating the need to switch to a controlled pressurized gas source. Ranjani Sundharam, An Son Leong, Lauren Kacmarcik, Andrew Koch MilliporeSigma, 80 Ashby Road, Bedford, MA 01730 A B 0 10 20 30 40 50 60 70 Blow-down Method Hold-upvolume(mL) Hold-up of Millipak® Final Fill 200 Filters Following Blow-down Gravity Drain Pressure increase to membrane BP through AMPP Presssure through inlet to 20 psi above BP for 1 min Pressure through AMPP to 20 psi above BP for 1 min